Eli Lilly and Company


Lilly unites caring with discovery to create medicines that make life better for people around the world.

Through investments in people, medicines and health systems, we strive to improve access to quality health care for 30 million people living in settings with limited resources annually by 2030. We call this global effort Lilly 30×30. To achieve our goal, we are leveraging the company’s resources and collaborating with leading health organizations to increase access to Lilly medicines and address complex global health challenges. We work to enhance health across three areas of impact:

  • Pipeline — discovering medicines, repurposing internal assets and supporting external pipelines
  • Programs – strengthening and creating new programs that help improve access to Lilly medicines
  • Partnerships — building partnerships that strengthen health systems, increase access to medicines and improve care.

In each of these areas, we are working to develop high-impact, scalable solutions for people living in communities with limited resources.